Amanote Research
Register
Sign In
Pcn98 - Palliative Treatment and Its Cost in the Last Six Months of Life for Metastatic Colorectal Cancer Patients
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.09.180
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2018
Authors
G. Merth
Rumszauer Á
D. Mokrai
V. Ruzsa
G. Füleki
L. Halmai
P. Rózsa
Publisher
Elsevier BV
Related search
Trajectory of Performance Status and Symptom Scores for Patients With Cancer During the Last Six Months of Life
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Palliative Radiotherapy in Patients With a Symptomatic Pelvic Mass of Metastatic Colorectal Cancer
Radiation Oncology
Nuclear Medicine
Radiology
Imaging
Oncology
Transarterial Chemoembolisation in the Treatment of Patients With Metastatic Colorectal Cancer
I.P. Pavlov Russian Medical Biological Herald
Cost of Disease Progression in Patients With Metastatic Breast, Lung, and Colorectal Cancer
Oncologist
Cancer Research
Medicine
Oncology
The Role of microRNA in Metastatic Colorectal Cancer and Its Significance in Cancer Prognosis and Treatment.
Acta Biochimica Polonica
Biochemistry
Genetics
Molecular Biology
Advances in the Treatment of Metastatic Colorectal Cancer
Disease-a-Month
Medicine
Resource Use in the Last Three Months of Life by Lung Cancer Patients in Southern Ontario
Current Oncology
Oncology
Inventory of Oncologists’ Unmet Needs for Tools to Support Decision-Making About Palliative Treatment for Metastatic Colorectal Cancer
BMC Medical Informatics and Decision Making
Health Policy
Health Informatics
Bevacizumab for Metastatic Colorectal Cancer: A Global Cost‐Effectiveness Analysis
Oncologist
Cancer Research
Medicine
Oncology